• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中最大吸气压的决定因素

Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease.

作者信息

Rochester D F, Braun N M

出版信息

Am Rev Respir Dis. 1985 Jul;132(1):42-7. doi: 10.1164/arrd.1985.132.1.42.

DOI:10.1164/arrd.1985.132.1.42
PMID:4014871
Abstract

Inspiratory muscle strength in COPD could be reduced either because of mechanical disadvantage consequent to increased lung volume or because respiratory muscles share in generalized muscle weakness. To assess the relative contributions of these factors, we measured maximal inspiratory and expiratory pressures (Pimax, Pemax, cmH2O) at RV and TLC, respectively, in 32 patients with COPD. The TLC, RV, and diaphragm length index at RV (DLI, cm/cm height) were determined roentgenographically and compared with values from 22 normal subjects studied at comparable lung volume. Half the patients with COPD had normal and half had low values of Pemax, but both groups had similar values of TLC, RV, and DLI. In patients with COPD, Pimax correlated (p less than 0.001) with Pemax (r = 0.73) and DLI (r = 0.64). The slope of the Pimax-DLI relationship was essentially the same in both groups of patients with COPD as it was in the normal subjects. However, at any value of DLI, Pimax was in the normal range in patients with normal Pemax, but significantly lower in patients with low Pemax (p less than 0.001). Expressing Pimax as a combined function of Pemax and DLI yielded the highest correlation (r = 0.84, p less than 0.001), with Pemax explaining 46% and DLI explaining 35% of the variance in Plmax not explained by the other variable alone (p less than 0.001). The PaCO2 was elevated in 13 of 18 patients whose Pimax was less than 55 cm H2O, and inversely correlated with Pimax (r = -0.66, p less than 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

慢性阻塞性肺疾病(COPD)患者吸气肌力量降低,可能是由于肺容积增加导致机械劣势,或者是呼吸肌存在全身性肌无力。为评估这些因素的相对作用,我们分别测量了32例COPD患者在残气量(RV)和肺总量(TLC)时的最大吸气和呼气压力(Pimax、Pemax,单位为cmH2O)。通过X线测定TLC、RV以及RV时的膈肌长度指数(DLI,单位为cm/cm身高),并与22名在相似肺容积下研究的正常受试者的值进行比较。一半COPD患者的Pemax值正常,另一半则较低,但两组的TLC、RV和DLI值相似。在COPD患者中,Pimax与Pemax(r = 0.73)和DLI(r = 0.64)相关(p < 0.001)。COPD两组患者中Pimax - DLI关系的斜率与正常受试者基本相同。然而,在任何DLI值时,Pemax正常的患者Pimax在正常范围内,而Pemax低的患者Pimax显著更低(p < 0.001)。将Pimax表示为Pemax和DLI的联合函数时相关性最高(r = 0.84,p < 0.001),Pemax解释了Pimax变异中46%的部分,DLI解释了单独由另一个变量未解释的Pimax变异中35%的部分(p < 0.001)。18例Pimax小于55 cm H2O的患者中有13例动脉血二氧化碳分压(PaCO2)升高,且与Pimax呈负相关(r = -0.66,p < 0.005)。(摘要截断于250字)

相似文献

1
Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中最大吸气压的决定因素
Am Rev Respir Dis. 1985 Jul;132(1):42-7. doi: 10.1164/arrd.1985.132.1.42.
2
[Indirect evaluation of respiratory muscle strength with the help of markers of maximal inspiratory and expiratory pressure in the mouth of healthy individuals].[借助健康个体口腔最大吸气和呼气压力指标对呼吸肌力量进行间接评估]
Pol Merkur Lekarski. 2002 Mar;12(69):178-80.
3
[Maximal respiratory pressure: normal values and changes in chronic obstructive pulmonary disease (COPD)].[最大呼吸压力:慢性阻塞性肺疾病(COPD)的正常值及变化]
Zhonghua Jie He He Hu Xi Za Zhi. 1989 Apr;12(2):73-5, 125.
4
[Age-related changes in static maximal inspiratory and expiratory pressures].[静态最大吸气和呼气压力的年龄相关变化]
Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Dec;35(12):1305-11.
5
[The effect of aging on respiratory muscle function].
Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Jul;29(7):795-801.
6
Muscle impairment in neuromuscular disease using an expiratory/inspiratory pressure ratio.使用呼气/吸气压力比值评估神经肌肉疾病中的肌肉损伤
Respir Care. 2015 Apr;60(4):533-9. doi: 10.4187/respcare.03367. Epub 2015 Jan 13.
7
Inspiratory muscle function in patients with severe kyphoscoliosis.
Am Rev Respir Dis. 1985 Jul;132(1):48-52. doi: 10.1164/arrd.1985.132.1.48.
8
A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼吸困难评分、呼吸肌力量和肺功能的因素分析。
Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):467-70. doi: 10.1164/ajrccm/145.2_Pt_1.467.
9
Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure.吸气肌力量是慢性心力衰竭患者最大耗氧量的一个决定因素。
Br Heart J. 1995 Oct;74(4):381-5. doi: 10.1136/hrt.74.4.381.
10
The value of multiple tests of respiratory muscle strength.呼吸肌力量多项测试的价值
Thorax. 2007 Nov;62(11):975-80. doi: 10.1136/thx.2006.072884. Epub 2007 Jun 8.

引用本文的文献

1
Evaluation of respiratory muscle dysfunction in patients with idiopathic pulmonary fibrosis: a prospective observational study with magnetic resonance imaging.特发性肺纤维化患者呼吸肌功能障碍的评估:一项磁共振成像的前瞻性观察研究。
BMC Pulm Med. 2025 Mar 14;25(1):118. doi: 10.1186/s12890-025-03572-6.
2
Role of quantitative planar lung perfusion scintigraphy and tomography in identifying target lobes in patients with emphysematous phenotype of advanced chronic obstructive pulmonary disease: a retrospective cross-sectional study.定量平面肺灌注闪烁显像和断层扫描在识别晚期慢性阻塞性肺疾病气肿型患者目标肺叶中的作用:一项回顾性横断面研究
Quant Imaging Med Surg. 2024 Sep 1;14(9):6425-6435. doi: 10.21037/qims-24-125. Epub 2024 Aug 19.
3
Lung Hyperinflation as Treatable Trait in Chronic Obstructive Pulmonary Disease: A Narrative Review.肺过度充气可作为慢性阻塞性肺疾病的一种可治疗的特征:一项叙述性综述。
Int J Chron Obstruct Pulmon Dis. 2024 Jul 2;19:1561-1578. doi: 10.2147/COPD.S458324. eCollection 2024.
4
Differences in Pulmonary and Extra-Pulmonary Traits between Women and Men with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病女性和男性在肺部及肺外特征上的差异。
J Clin Med. 2022 Jun 26;11(13):3680. doi: 10.3390/jcm11133680.
5
Diaphragm Dysfunction and Rehabilitation Strategy in Patients With Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者的膈肌功能障碍与康复策略
Front Physiol. 2022 May 2;13:872277. doi: 10.3389/fphys.2022.872277. eCollection 2022.
6
Chronic non-invasive ventilation for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的慢性无创通气。
Cochrane Database Syst Rev. 2021 Aug 9;8(8):CD002878. doi: 10.1002/14651858.CD002878.pub3.
7
Development and Relevance of Hypercapnia in COPD.慢性阻塞性肺疾病中高碳酸血症的发生与相关性。
Can Respir J. 2021 Feb 22;2021:6623093. doi: 10.1155/2021/6623093. eCollection 2021.
8
Prevalence Of Chronic Hypercapnia In Severe Chronic Obstructive Pulmonary Disease: Data From The HOmeVent Registry.慢性阻塞性肺疾病患者慢性高碳酸血症的患病率:来自 HOmeVent 登记处的数据。
Int J Chron Obstruct Pulmon Dis. 2019 Oct 18;14:2377-2384. doi: 10.2147/COPD.S222803. eCollection 2019.
9
Physical signs in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的体征
Lung India. 2019 Jan-Feb;36(1):38-47. doi: 10.4103/lungindia.lungindia_145_18.
10
Lung hyperinflation and functional exercise capacity in patients with COPD - a three-year longitudinal study.慢性阻塞性肺疾病患者的肺过度充气和功能运动能力 - 一项为期三年的纵向研究。
BMC Pulm Med. 2018 Dec 6;18(1):187. doi: 10.1186/s12890-018-0747-9.